Dr. Behnam Heidari, MD, MPH

Dr. Heidari practices at John Sealy Hospital in Galveston, Texas, part of The University of Texas System.

Dr. Heidari's NPI, 1811458995, was assigned on March 29, 2019. Dr. Heidari graduated from Tehran University of Medical Sciences School of Medicine in 2013. Dr. Heidari holds Texas license T4527.

Dr. Heidari's primary practice is John Sealy Hospital, at 301 University Boulevard, Galveston, TX 77555 in Galveston County. The practice phone is (409) 772-1011.

Dr. Heidari's primary practice is John Sealy Hospital in Galveston, Texas, part of The University of Texas System. Dr. Heidari is also affiliated with The University of Texas MD Anderson Cancer Center. The medical group on file is XpertMD. Dmand AI also links Dr. Heidari to 1 more group practice or clinic and 1 medical group, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Heidari practices, 3 sites in all. Vendor and product names are available with a free account.

Internal medicine is Dr. Heidari's primary specialty in the NPI Registry, under taxonomy code 207R00000X. Dr. Heidari is board certified in internal medicine by the American Board of Internal Medicine. Dr. Heidari is licensed in Texas.

Dmand AI lists acute diabetes, acute respiratory failure, atrial fibrillation and flutter, bile duct problems, cardiac arrhythmia, cellulitis, chest pain and circulatory problems in extremities among the conditions Dr. Heidari treats.

CMS data shows 1,322 Medicare services from Dr. Heidari across 4 procedure codes in 2024, for 510 Medicare patients. Medicare paid $119,622 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 510 Medicare patients who saw Dr. Heidari in 2024. The largest group is 75 to 84, with 171 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 20% are also on Medicaid. Their average risk score is 2.64, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Heidari's median patient age at 73, with 56% women.

In 2024, Dr. Heidari wrote 601 Medicare Part D claims for 304 patients. 87% of them were for generic drugs. CMS names the drug for 273 of them, across 12 drugs with 11 or more claims each, at $9,675 in total drug cost. In 2023, CMS named 355 claims across 17 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 75 out of 100 for Dr. Heidari for performance year 2024, reported as part of a group.

Dmand AI links 10 papers to Dr. Heidari, published from 2018 to 2023. 2019 was the busiest year, with 2. The most frequent topics are Aortic Valve Stenosis and Transcatheter Aortic Valve Replacement. Dr. Heidari has published most often in Curr Atheroscler Rep. Dr. Heidari's most frequent co-authors are Mackram F. Eleid, MD, Rajiv Gulati, MD and Charanjit S. Rihal, MD.

CMS Open Payments shows 4 general payments to Dr. Heidari from 3 drug and device companies from 2022 to 2025. Food and beverage make up the largest share, 100% of the total. Abbvie Inc. paid the most, $50.

Dr. Heidari graduated from Tehran University of Medical Sciences School of Medicine in 2013.

Dr. Heidari is in network with 19 carriers, including Blue Cross Blue Shield of Michigan, United Healthcare and Aetna. PPO plans come from the most carriers, 11. Check the plan with the practice before a visit.